Case Reports

Imatinib mesylate can induce complete molecular remission in FIP1L1-PDGFR-a positive idiopathic hypereosinophilic syndrome

Institute of Hematology and Medical Oncology "L and A Seragnoli", University of Bologna, Italy.
Institute of Hematology and Medical Oncology "L and A Seragnoli", University of Bologna, Italy.
Institute of Hematology and Medical Oncology "L and A Seragnoli", University of Bologna, Italy.
Institute of Hematology and Medical Oncology "L and A Seragnoli", University of Bologna, Italy.
Institute of Hematology and Medical Oncology "L and A Seragnoli", University of Bologna, Italy.
Institute of Hematology and Medical Oncology "L and A Seragnoli", University of Bologna, Italy.
Vol. 89 No. 2 (2004): February, 2004